Allan Gaw




After graduating in Medicine from the University of Glasgow in 1984 I trained in Clinical Biochemistry before specialising in Clinical Lipidology when I held the West of Scotland Coronary Prevention Study Lectureship for three years.

On completion of my Ph.D., which focussed on the metabolic mechanisms of cholesterol lowering drugs, I spent two years post doctoral study funded by the British Heart Foundation (BHF) in the laboratories of the Nobel Laureates, Joseph Goldstein and Michael Brown in Dallas, Texas. During that time I worked on the molecular genetics of familial cholesterol disorders.

I returned to the UK to take up a position which was funded by a BHF Intermediate Fellowship, in the Department of Pathological Biochemistry at the Glasgow Royal Infirmary.

My current interests are the study of cholesterol lowering drug therapies, the primary and secondary prevention of coronary heart disease, cardiovascular disease prevention in the elderly, the design and conduct of clinical trials and medical education.

In 1997 I was appointed Deputy Study Director of PROSPER and in 2000 I took over the leadership of the Clinical Trials Unit at Glasgow Royal Infirmary.

In 2006 I was appointed Director of Operations of the Glasgow Clinical Research Facility and in 2011 I was appointed to the Chair of Clinical Research in Queen's University Belfast and as the Director of the Wellcome Trust/Wolfson Northern Ireland Clinical Research Facility.

In 2012 I became the Associate Director for Educational Quality Standards at the National Institute for Health Research Clinical Research Network (NIHR-CRN) at the University of Leeds and embarked on a freelance teaching and writing career.

I am the author of over 145 original papers, reviews and book chapters on cholesterol and coronary heart disease and clinical trials, and have authored or edited 14 textbooks on subjects such as Clinical Biochemistry, Coronary Heart Disease Prevention, the Pharmacology of the Statins, Statins in General Practice, Lipids and Atherosclerosis and the Use of Statins in Stroke Prevention.

More info here.

E.g., 2016-10-24
E.g., 2016-10-24
E.g., 2016-10-24
Jun 6th 2016

Find out how medical treatments are discovered, tested and evaluated, to improve healthcare for all, on this free online course. Everything we do in healthcare - every tablet that’s prescribed, every treatment that’s given and every test that’s performed - has to be first discovered and then thoroughly evaluated before it can be put into practice.

No votes yet